The efficacy and safety of anti-TNF agents in the treatment of Intestinal Behcet's disease, a systematic review and meta-analysis.

Mengyuan ZhangJinjing LiuTingting LiuWei HanXiaoyin BaiGechong RuanHong LvHuijun ShuYue LiJing-Nan LiBei TanWeiyang ZhengHui XuWenjie ZhengHong Yang Jia-Ming Qian

Published in: Journal of gastroenterology and hepatology (2021)

Anti-TNF agents, including infliximab, adalimumab, was an efficient therapy for intestinal Behcet's disease. The safety of anti-TNF agents used in the treatment of intestinal Behcet's disease was acceptable.

Keyphrases

rheumatoid arthritis
combination therapy
ulcerative colitis
disease activity